News at a Glance: Stocks, Economy, and Latest Headlines
- Latest
- Stock Market News
- Economic News
Summary The Commerce Department shared a report on slowing consumer spending in the past month. Decreases in expenditures on durables like motor ...
Summary The seasonally adjusted PMI witnessed a rise to 51.7 points in February. Improvement seen in the business activity sub-index and new sales ...
Inflation Trends in the UK Recent data reveals that inflation in the UK has surged by 2.3%, exceeding the anticipated increase of 2.2%. This uptrend is ...
Summary Consumer prices in Colombia are expected to rise by 0.94% in February, significantly lower than the 1.66% of the previous year. Estimates for ...
Summary Chinese manufacturing activity showed an unexpected growth in February according to a private report. The Caixin Purchasing Managers’ Index ...
Summary The service sector in China grew at a slower rate than anticipated in February, despite the Lunar New Year holiday stimulus, as per findings of ...
As Tokyo inflation data surpasses expectations, the yen seesaws at the crucial 150 mark against the US dollar, fuelling speculation about an impending Bank ...
The crypto markets experienced a dramatic surge on Tuesday night as bitcoin surges and investors, buoyed by the anticipation of a potential Donald Trump ...
Summary Strong capital expenditure (capex) data may strengthen arguments for a shift in the central bank's ultra-accommodative monetary policy. ...
Summary The Combined Purchasing Managers Index for the UK, which includes services and manufacturing sectors, shows a slight increase to 53.0 from ...
Summary According to Goldman Sachs analysts, automakers' recent price reductions in electric vehicles (EV) have drawn significant investor attention amidst ...
Summary Revance Therapeutics, Inc., a NASDAQ-listed biotechnology company, unveils its plans for a $100 million public offering of its common stock. The funds ...
© 2026 PIP PENGUIN
Disclaimer Notices
The content on this site encompasses general news, our analyses, opinions, and material from third-party sources, all designed for educational and research aims. It is not meant as direct advice or a prompt to undertake any specific action, including investments or purchases. Before making financial decisions, we urge you to conduct thorough research, exercise personal judgment, and consult with professionals. The content is not tailored to individual financial circumstances or needs. Information on this website might not be in real-time or entirely accurate, with prices potentially sourced from market participants rather than exchanges. Any financial decisions you make are your sole responsibility, and reliance on any site information is at your own risk. PipPenguin makes no guarantees regarding the website’s information accuracy and will not be liable for any trading losses or other losses incurred from using this site. The site may contain ads and promotional content, for which PipPenguin could receive third-party compensation. However, this does not imply endorsement or recommendation of any third party’s services, and we are not responsible for your use of any external site or service. PipPenguin and its staff, executives, and affiliates disclaim liability for any loss or damage from using the site or its information.
Risk Disclaimers
This site provides information on cryptocurrencies, CFDs, and various financial instruments, along with details about brokers and trading platforms. These instruments are complex and carry a significant risk of loss. It’s important to fully understand how they work and assess if you can afford the associated risks before investing. We encourage doing extensive research before any investment and caution against investing in instruments that are not fully understood.